UK markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
257.68-1.25 (-0.48%)
At close: 04:00PM EDT
257.70 +0.02 (+0.01%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 37.50B
Enterprise value 38.01B
Trailing P/E 14.12
Forward P/E 15.38
PEG ratio (5-yr expected) 5.14
Price/sales (ttm)3.77
Price/book (mrq)2.59
Enterprise value/revenue 3.81
Enterprise value/EBITDA 9.96

Trading information

Stock price history

Beta (5Y monthly) 0.13
52-week change 332.28%
S&P500 52-week change 318.47%
52-week high 3319.76
52-week low 3194.63
50-day moving average 3266.74
200-day moving average 3281.70

Share statistics

Avg vol (3-month) 31.01M
Avg vol (10-day) 3780.86k
Shares outstanding 5144.82M
Implied shares outstanding 6144.82M
Float 8144.38M
% held by insiders 10.68%
% held by institutions 190.87%
Shares short (30 Aug 2023) 43.14M
Short ratio (30 Aug 2023) 43.81
Short % of float (30 Aug 2023) 42.44%
Short % of shares outstanding (30 Aug 2023) 42.17%
Shares short (prior month 30 Jul 2023) 43.42M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 317 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin 26.72%
Operating margin (ttm)26.24%

Management effectiveness

Return on assets (ttm)6.51%
Return on equity (ttm)20.25%

Income statement

Revenue (ttm)9.97B
Revenue per share (ttm)69.08
Quarterly revenue growth (yoy)-5.10%
Gross profit (ttm)7.9B
Net income avi to common (ttm)2.66B
Diluted EPS (ttm)18.23
Quarterly earnings growth (yoy)-44.10%

Balance sheet

Total cash (mrq)6.08B
Total cash per share (mrq)41.97
Total debt (mrq)6.59B
Total debt/equity (mrq)45.57%
Current ratio (mrq)3.27
Book value per share (mrq)99.91

Cash flow statement

Operating cash flow (ttm)1.43B
Levered free cash flow (ttm)1.71B